Perche PO - Search Results

1

Patient willingness to receive full-body skin exams based on the sex and/or gender and training level of provider: a survey study.

Perche PO, Ranpariya VK, Swali RN, Clarey DD, Wysong A, Feldman SR. Perche PO, et al. Clin Exp Dermatol. 2022 Oct;47(10):1853-1856. doi: 10.1111/ced.15260. Epub 2022 Jul 3. Clin Exp Dermatol. 2022. PMID: 35546559

2

Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis.

Fardos MI, Singh R, Perche PO, Kelly KA, Feldman SR. Fardos MI, et al. Among authors: perche po. Expert Rev Clin Immunol. 2022 Mar;18(3):221-231. doi: 10.1080/1744666X.2022.1993061. Epub 2021 Oct 22. Expert Rev Clin Immunol. 2022. PMID: 34637367 Review.

3

The relative weak way and the absolute strong way to communicate risk information.

Perche PO, Cook MK, Feldman SR. Perche PO, et al. J Dermatolog Treat. 2022 May;33(3):1205-1207. doi: 10.1080/09546634.2021.1995982. J Dermatolog Treat. 2022. PMID: 34666590 Free article. No abstract available.

4

The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications.

Singh R, Koppu S, Perche PO, Feldman SR. Singh R, et al. Among authors: perche po. Int J Mol Sci. 2021 Nov 26;22(23):12793. doi: 10.3390/ijms222312793. Int J Mol Sci. 2021. PMID: 34884596 Free PMC article. Review.

5

Comparing available JAK inhibitors for treating patients with psoriasis.

Funk PJ, Perche PO, Singh R, Kelly KA, Feldman SR. Funk PJ, et al. Among authors: perche po. Expert Rev Clin Immunol. 2022 Mar;18(3):281-294. doi: 10.1080/1744666X.2022.2039121. Epub 2022 Feb 10. Expert Rev Clin Immunol. 2022. PMID: 35129030

6

Greater rosacea severity correlates with greater adherence and improvement in a clinical study.

Perche PO, Singh R, Cook MK, Kelly KA, Balogh EA, Richardson I, Feldman SR. Perche PO, et al. J Am Acad Dermatol. 2023 Jan;88(1):209-210. doi: 10.1016/j.jaad.2022.04.037. Epub 2022 Apr 28. J Am Acad Dermatol. 2023. PMID: 35490832 No abstract available.

7

The Role of Anticipation in Patient Adherence.

Nguyen PM, Perche PO, Feldman SR. Nguyen PM, et al. Among authors: perche po. South Med J. 2022 May;115(5):315-316. doi: 10.14423/SMJ.0000000000001386. South Med J. 2022. PMID: 35504612 No abstract available.

8

Abrocitinib: A New FDA-Approved Drug for Moderate-to-Severe Atopic Dermatitis.

Perche PO, Cook MK, Feldman SR. Perche PO, et al. Ann Pharmacother. 2023 Jan;57(1):86-98. doi: 10.1177/10600280221096713. Epub 2022 May 19. Ann Pharmacother. 2023. PMID: 35587593 Review.

9

Hidradenitis Suppurativa's Impact on Social Activities: An Observational Study.

Perche PO, Singh R, Senthilnathan A, Feldman SR, Pichardo RO. Perche PO, et al. Cureus. 2022 May 24;14(5):e25292. doi: 10.7759/cureus.25292. eCollection 2022 May. Cureus. 2022. PMID: 35637919 Free PMC article.

10

Oral Vitamin A for Acne Management: A Possible Substitute for Isotretinoin.

Cook M, Perche P, Feldman S. Cook M, et al. J Drugs Dermatol. 2022 Jun 1;21(6):683-686. doi: 10.36849/JDD.6781. J Drugs Dermatol. 2022. PMID: 35674761 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters